The efficacy of ocrelizumab for multiple sclerosis
This summary will present the most up to date findings from a recent Cochrane review.1
Background
It is estimated that a total of 2.8 million people...
Sustainable pharmacy practice is the order of the day
A resounding theme at the FIP World Congress of Pharmacy and Pharmaceutical Sciences in Brisbane is the need for action on climate change.
Case study: Getting to the bottom of Rosa’s sleep problems
Allergic rhinitis (AR), commonly known as hayfever, affects around 19% of Australians. This case study explores how it impacts sleep quality.
Meet PSA’s new President
The new President of the Pharmaceutical Society of Australia (PSA) is Dr Chris Freeman – currently Clinical Senior Lecturer and the Director of the...
Fostering culturally safe care
With empathy, openness and a listening ear, pharmacists can make a big impact in Aboriginal Health Services — for both community members and staff.
Intracavernosal injection therapy for erectile dysfunction
When first-line therapies don't work, intracavernosal injections can be a welcome option for patients with erectile dysfunction.
